Ernexa Therapeutics Inc.: Form 8-K, filed Feb 2, 2016
Filed with the SEC on Feb 2, 2016 and accepted by EDGAR at Feb 2, 2016, 07:15 ET.
Items reported
- Item 3.01 Delisting notice
- Item 5.02 Departure or appointment of officers or directors
- Item 8.01 Other events
- Item 9.01 Financial statements and exhibits
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001019687-16-004980. Last ingested by Listed: Nov 11, 2026, 02:49 ET. Listed shows no prices and gives no investment advice.